Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
26.5M
-
Shares change
-
+4.82M
-
Total reported value, excl. options
-
$277M
-
Value change
-
+$55.3M
-
Put/Call ratio
-
0.9
-
Number of buys
-
71
-
Number of sells
-
-48
-
Price
-
$10.46
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q4 2015
143 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q4 2015.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.5M shares
of 119M outstanding shares and own 22.18% of the company stock.
Largest 10 shareholders include BVF INC/IL (2.92M shares), LANSDOWNE PARTNERS (UK) LLP (2.32M shares), FMR LLC (2.15M shares), EcoR1 Capital, LLC (1.42M shares), BlackRock Institutional Trust Company, N.A. (1.31M shares), VANGUARD GROUP INC (1.28M shares), ACADIAN ASSET MANAGEMENT LLC (1.17M shares), BlackRock Fund Advisors (919K shares), STATE STREET CORP (801K shares), and CITIGROUP INC (723K shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.